A ten-week trial in Germany found that a prescription cannabis medicine cut nightmares in people with post-traumatic stress disorder, with more than a third of patients saying their nightmares stopped...

A University of Florida survey of 108 people with Crohn's disease and ulcerative colitis found that most reported a better quality of life and reduced opioid use after turning to cannabis.

Ontario-based MediPharm Labs Corp. shared the results from the Phase II LiBBY (Life's End Benefits of Cannabidiol and Tetrahydrocannabinol) trial at the Alzheimer's Association International...

Showed greatest efficacy in patients with multiple sclerosis

Marihuana Tax Act signed on August 2, 1937

The Medical Cannabis Clinicians Society has published a comprehensive 189-page guide providing evidence-based medical cannabis oil dosing protocols for 12 conditions, addressing a critical gap in clin...

Nearly 22% of Americans ages 55 to 65

Acknowledging legitimate therapeutic utility is long overdue

Senate Democrats have filed a bill to federally legalize marijuana, a far-reaching proposal that comes as the Trump administration is moving ahead with a more incremental reform to reschedule cannabis...

An estimated one in five US adults suffers from a chronic pain condition of a…

The study finds medical marijuana users report significant improvements in quality of life, pain, energy, and functioning over 3 months of treatment.

This paper aims to evaluate the anti-emetic efficacy of cannabinoids in cancer patients receiving chemotherapy using a systematic review of literature searched within electronic databases such as PUBM...

In this review, we discuss the potential role of cannabis and cannabinoids in the management of cancer-related symptoms. There is limited evidence demonstrating the effectiveness of cannabis-based pro...